Company intelligence / Profile preview

Nordea

Madhya Pradesh, Indianordea.com ↗

Ownership: Public · NDAFI
Development stage: Commercial

Overview

Nordea Lifescience is a commercial-stage pharmaceutical and healthcare company offering a wide range of generic medicines and medical consumables. They manufacture products at WHO cGMP-certified facilities in India. The company also produces medical wipes and sanitizers on an OEM basis. No clinical trial results are reported as they focus on established formulations rather than novel drug development.

Therapeutic areas: OtherDermatologyOphthalmologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

No major pharmaceutical or biotech partnerships disclosed in available sources. The company does offer OEM manufacturing for other brands.

Financials

Market cap: $4.4M
Total revenue: $0

Beyond the preview

Go deeper on Nordea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nordea.

Explore the full profile